Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

@article{Lagergren1999SymptomaticGR,
  title={Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.},
  author={Jesper Lagergren and Reinhold Bergstr{\"o}m and Anders Lindgren and Olof Nyrén},
  journal={The New England journal of medicine},
  year={1999},
  volume={340 11},
  pages={
          825-31
        }
}
BACKGROUND The causes of adenocarcinomas of the esophagus and gastric cardia are poorly understood. We conducted an epidemiologic investigation of the possible association between gastroesophageal reflux and these tumors. METHODS We performed a nationwide, population-based, case-control study in Sweden. Case ascertainment was rapid, and all cases were classified uniformly. Information on the subjects' history of gastroesophageal reflux was collected in personal interviews. The odds ratios… 
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
TLDR
Gastroesophageal reflux is strongly associated with the risk of esophagal adenocarcinoma, and to a lesser extent, with gastric cardia adenOCarcinomas, and after antireflux surgery.
Heredity and risk of cancer of the esophagus and gastric cardia.
  • J. Lagergren, W. Ye, A. Lindgren, O. Nyrén
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2000
TLDR
Hredity does not seem to contribute importantly to the occurrence of esophageal cancer of any histological type, and a weak association between familial gastric cancer and the risk of cardia cancer may represent a genetic link.
Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
  • R. Erichsen, D. Robertson, +4 authors H. Sørensen
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2012
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
TLDR
Individuals with long-standing GERD are at increased risk of esophageal adenocarcinoma, whether or not the symptoms are treated with H2blockers or antacids.
Subsite-Specific Risk Factors for Esophageal and Gastric Adenocarcinoma
TLDR
This identification of distinct risk factors by subsite supports the concept that esophageal and gastric adenocarcinomas are two different diseases.
Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma
TLDR
It was found that reflux had a strong association with oesophageal adenocarcinoma, a … Lagergren et al found that rebreathing problems, including acid reflux, were linked with cancer by at least five years before the diagnosis of cancer.
Relationship of Gastroesophageal Reflux Disease with Adenocarcinoma of the Distal Esophagus and Cardia
TLDR
Patients with gastroesophageal junction adenocarcinoma had a higher prevalence of GERD-like symptoms compared to age- and gender-matched controls, which supports an association between GERD and gastroeastern junction cancers.
Esophagitis: Incidence and Risk of Esophageal Adenocarcinoma—A Population-Based Cohort Study
TLDR
The risk of esophageal adenocarcinoma is increased fivefold in patients with previously diagnosed esophagitis, but most of the adenOCarcinomas occurred among patients with Barrett's esophagus.
Etiological aspects of gastroesophageal cancers : An epidemiological approach
TLDR
Overall dietary habits seem to play an important role in the carcinogenesis of esophageal and cardia cancer, whereas a dietary pattern characterized by high beer and liquor intake significantly increased the risk of squamous-cell carcinoma of the esophagus.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia
TLDR
Findings provide reassuring findings that use of H 2 antagonists and anticholinergics does not increase AEC risk and quantifies the elevated risk of AEC associated with gastroesophageal reflux disease.
Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors.
  • Z. F. Zhang, R. Kurtz, +6 authors S. Harlap
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 1996
TLDR
It is suggested that medical conditions such as hypertension and iron deficiency may be related to the risk of adenocarcinomas of esophagus and gastric cardia and confirms the moderate risk associated with tobacco smoking.
Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study
TLDR
Endoscopic surveillance to detect dysplasia may be an option for the individual patient with Barrett's esophagus, but these screening programs are not likely to reduce the death rate from esophageal adenocarcinomas in the general population.
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.
TLDR
Increasing prevalence of obesity in the United States population may have contributed to the upward trends in esophageal and gastric cardia adenocarcinomas.
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.
TLDR
Because of the long lag time before risk of these tumors is reduced among ex-smokers, smoking may affect early stage carcinogenesis.
Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
TLDR
Adenocarcinomas located at the gastroesophageal junction were associated with Barrett's metaplasia in nearly one half of the patients, and the presence of high-grade dysplasia within Barrett's mucosa supports a barrett's origin forhalf of the adenocARCinomas arising at this location.
Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
  • R. Kim, J. Weissfeld, J. Reynolds, L. Kuller
  • Medicine
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 1997
TLDR
What is currently known about the epidemiology of Barrett's metaplasia, its risk for malignant transformation, and the proposed theories of etiogenesis are reviewed.
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
TLDR
A larger and has a longer follow-up period than previous prospective trials and demonstrates a lower incidence of adenocarcinoma in patients with Barrett's esophagus.
...
1
2
3
4
...